Media

Ignyta and EORTC Announce Entrectinib as 1st Investigational Cancer Agent in EORTC SPECTA

in Media, Press Releases

research-2

SAN DIEGO and BRUSSELS–(BUSINESS WIRE)–Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, and the European Organisation for Research and Treatment of Cancer (EORTC) today announced that they will collaborate via EORTC’s Screening Patients for Efficient Clinical Trial Access (SPECTA) biomarker screening initiative to identify patients who harbor a gene rearrangement to NTRK1, NTRK3, ROS1… Read more »

Over 17.000£ raised at the 2015 edition of the ParkLife event!

in Fundraising, Media

150716_Parklife_5d-383

The 2015 edition of the ParkLife event proved a great success in Hyde Park, London. Many Walgreens Boots Alliance employees from Sedley, nike air max pas cher Chessington, sac fjällräven kånken Nottingham and Brooklands, as well as representatives of the EORTC and major sponsors took great pride in making this event a celebration of health… Read more »

SPECTAcolor viable next generation multinational cancer clinical trial infrastructure

in Media, Press Releases

dresden

Over 500 patients in and availability of high quality biological materials SPECTAcolor’s successful start has demonstrated its viability to facilitate next generation cancer clinical trials. Nike Air Max 2017 Heren blauw Nike Air Max 2016 Heren It has been successfully implemented across 21 clinical centers located in nine countries in Europe, has now recruited over… Read more »

Over €9,000 raised at the gala dinner of the Alphega Pharmacy Walgreens Boots Alliance convention in Monaco!

in Fundraising, Media, Meetings

AlphegaConventionCentre

Built on the theme of ‘Stay independent Lead the future’ the Alphega Pharmacy Walgreens Boots Alliance Convention took place from 5- 6 March 2015 in the beautiful surroundings of Monaco. air max 1 femme cheap adidas uk for sale SPECTAcolor was featured throughout the event exhibition with a stand among the booths of business representives… Read more »

14M Genomics and EORTC and Announce First Results from their Collaboration on Tumour Profiling

in Media, Press Releases, Science

14mg

Cambridge, UK: 16 November 2015. Chaussures Asics Homme tn requin pas cher 14M Genomics (“14MG”) and The European Organisation for Research and Treatment of Cancer (“EORTC”) today announce the delivery of initial genomic mutation analyses conducted on newly diagnosed cancer patients as part of the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) programme…. Read more »